Systemic Lupus Erythematosus with Nephropathy

Overview

Journal Yale J Biol Med

Specialty Biology

Date 1995 May 1

PMID 8792600

Authors

J P HAYSLETT

H Carey

Affiliations

Soon will be listed here.

Abstract

This paper is the first in a new Clinical Feature Series that will be a regular feature in future issues of The Yale Journal of Biology and Medicine. Papers in the series will focus on cases and disease processes of general interest to the practicing clinician, with the goal being to present the perspectives of expert clinicians regarding the accurate diagnosis and effective treatment of the diseases being discussed. The following case was presented at Medical Grand Rounds at the Yale-New Haven Hospital and the Yale School of Medicine by John P. Hayslett, Professor of Medicine (Nephrology) with accompanying analysis of pathological specimens by Dr. Hugh Carey, a Postdoctoral Fellow of the Pathology staff. The patient whose case is presented was also present to describe her experience with the illness and the course of treatment.

References

Hecht B, Siegel N, Adler M, Kashgarian M, HAYSLETT J . Prognostic indices in lupus nephritis. Medicine (Baltimore). 1976; 55(2):163-81. DOI: 10.1097/00005792-197603000-00005. View

Austin 3rd H, Klippel J, Balow J, le Riche N, Steinberg A, Plotz P . Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986; 314(10):614-9. DOI: 10.1056/NEJM198603063141004. View

HAYSLETT J . The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol. 1992; 28(3-4):199-204. DOI: 10.1111/j.1600-0897.1992.tb00791.x. View

Jonsson H, Nived O, Sturfelt G . Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989; 68(3):141-50. View

Esdaile J, Joseph L, Mackenzie T, Kashgarian M, HAYSLETT J . The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol. 1994; 21(11):2046-51. View